Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30001781
Basic Information
VIS ID
TVIS30001781
Fusion event
HIV-SAMD8 integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr10
Cytoband
q22.2
Reference genome
GRCh37/hg19
Start
76904898/75145140 (Hg38)
End
76904898/75145140 (Hg38)
Orient
-
Location type
Intronic
Fragile sites / regions
FRA10D
Target gene
SAMD8
miRNAs that regulate target gene
hsa-mir-335-5p
;
hsa-mir-93-5p
;
hsa-mir-33a-5p
;
hsa-mir-32-5p
;
hsa-mir-19b-3p
;
hsa-mir-7-1-3p
;
hsa-mir-7-2-3p
;
hsa-mir-376a-3p
;
hsa-mir-376b-3p
;
hsa-mir-495-3p
;
hsa-mir-559
;
hsa-mir-576-3p
;
hsa-mir-548b-5p
;
hsa-mir-548a-5p
;
hsa-mir-548c-5p
;
hsa-mir-548d-5p
;
hsa-mir-548j-5p
;
hsa-mir-548h-5p
;
hsa-mir-548i
;
hsa-mir-548w
;
hsa-mir-548y
;
hsa-mir-548o-5p
;
hsa-mir-548ab
;
hsa-mir-548ad-5p
;
hsa-mir-548ae-5p
;
hsa-mir-548ak
;
hsa-mir-548am-5p
;
hsa-mir-548ap-5p
;
hsa-mir-548aq-5p
;
hsa-mir-548ar-5p
;
hsa-mir-548as-5p
;
hsa-mir-548au-5p
;
hsa-mir-5688
;
hsa-mir-548ay-5p
;
hsa-mir-548bb-5p
;
hsa-mir-17-5p
;
hsa-mir-19a-3p
;
hsa-mir-20a-5p
;
hsa-mir-106a-5p
;
hsa-mir-130a-3p
;
hsa-mir-106b-5p
;
hsa-mir-301a-3p
;
hsa-mir-130b-3p
;
hsa-mir-20b-5p
;
hsa-mir-519c-3p
;
hsa-mir-526b-3p
;
hsa-mir-519b-3p
;
hsa-mir-519d-3p
;
hsa-mir-520g-3p
;
hsa-mir-520h
;
hsa-mir-519a-3p
;
hsa-mir-454-3p
;
hsa-mir-301b-3p
;
hsa-mir-4295
;
hsa-mir-3666
;
hsa-mir-548aw
;
hsa-mir-143-3p
;
hsa-mir-4770
;
hsa-mir-6088
;
hsa-mir-3609
;
hsa-mir-548ah-5p
;
hsa-mir-4796-3p
;
hsa-mir-487a-3p
;
hsa-mir-154-3p
;
hsa-mir-8054
;
hsa-mir-548l
;
hsa-mir-548k
;
hsa-mir-548av-5p
;
hsa-mir-5096
;
hsa-mir-197-3p
;
hsa-mir-6832-5p
;
hsa-mir-4755-3p
;
hsa-mir-6086
;
hsa-mir-377-5p
;
hsa-mir-655-5p
;
hsa-mir-1279
;
hsa-mir-5089-5p
;
hsa-mir-5589-5p
;
hsa-mir-4731-5p
;
hsa-mir-6829-3p
;
hsa-mir-6791-3p
;
hsa-mir-6506-5p
;
hsa-mir-619-5p
;
hsa-mir-1295b-3p
;
hsa-mir-5009-3p
;
hsa-mir-512-3p
;
hsa-mir-520e
;
hsa-mir-520d-3p
;
hsa-mir-520c-3p
;
hsa-mir-520b
;
hsa-mir-520a-3p
;
hsa-mir-373-3p
;
hsa-mir-372-3p
;
hsa-mir-302e
;
hsa-mir-302d-3p
;
hsa-mir-302c-3p
;
hsa-mir-302b-3p
;
hsa-mir-302a-3p
;
hsa-mir-6802-3p
;
hsa-mir-1468-3p
;
hsa-mir-548x-5p
;
hsa-mir-548g-5p
;
hsa-mir-548f-5p
;
hsa-mir-548aj-5p
;
hsa-mir-500b-3p
;
hsa-mir-3973
;
hsa-mir-205-3p
;
hsa-mir-888-5p
;
hsa-mir-1912
;
hsa-mir-1295b-5p
;
hsa-mir-2114-3p
;
hsa-mir-576-5p
;
hsa-mir-4263
;
hsa-mir-4764-3p
;
hsa-mir-1976
;
hsa-mir-8073
;
hsa-mir-221-5p
;
hsa-mir-6747-3p
;
hsa-mir-6727-3p
;
hsa-mir-4722-3p
;
hsa-mir-660-3p
;
hsa-mir-5193
;
hsa-mir-5684
;
hsa-mir-603
Nearest miRNA
hsa-mir-1265/Upstream/2424040; hsa-mir-107/Downstream/407318;
Nearest TSS
ENST00000439456/Upstream/33431;
ENST00000470745/Downstream/65014;
Nearest CpG islands
None/Target,
chr10-CpG: 68/Upstream/33278
,
chr10-CpG: 109/Downstream/65094
Upstream sequence
cagattatttcattttatctctagaacttggagttgcgttagtctttttttacttatctatttccttttttgttgagatggtgcaggggcaggggacatc
Downstream sequence
tccctttgttgctcaggctgaccttgaactcctggccgcaagggatcctcctgccttgcctcccaaagtgcagggattacaggcgtgagccaccacctgg
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Active CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate